2. 您的位置
3. 首页
4. 会议论文
5. CALGB 70604 (Alliance): A randomized phase Ⅲ study of standard dosing vs. longer interval dosing of

CALGB 70604 (Alliance): A randomized phase Ⅲ study of standard dosing vs. longer interval dosing of

来源 :2015年临床肿瘤学新进展学术研讨会 | 被引量 : 0次 | 上传用户：liuyibi1987

【作 者】

：

Andrew Louis Himelstein Rui Qin Paul J. Novotny Drew K. Seisler James L. Khatcheressian John D.Roberts Stephen S. Grubbs Tracey O'Connor Douglas Weckstein Charles L. Loprinzi Charles L. Shapiro 

【机 构】

：

HelenF. Graham Cancer Center & Research Institute, Newark, DE

【出 处】

：

2015年临床肿瘤学新进展学术研讨会

【发表日期】

：

2015年3期

下载到本地 , 更方便阅读

下载此文 赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

其他文献

Relationship between PD-L1 expression and clinical outcomes in patients with advanced gastric cancer

会议

A phase Ⅲ protocol of androgen suppression (AS) and 3DCRT/IMRT versus AS and 3DCRT/IMRT followed by

会议

Interest of short hormonotherapy (HT) associated with radiotherapy (RT) as salvage treatment for bio

会议

Defining a molecular subclass of treatment resistant prostate cancer

会议

First-line randomized phase Ⅱ study of gemcitabine/cisplatin plus apatorsen or placebo in patients w

会议

TROG 03.06 and VCOG PR 01-03: The “timing of androgen deprivation therapy in prostate cancer patient

会议

A phase Ⅱ/Ⅲ, double-blind, randomized trial comparing maintenance lapatinib versus placebo after fir

会议

Phase Ⅲ trials of anamorelin in patients with advanced non-small cell lung cancer (NSCLC) and cachex

会议

Long-term safety of fertility preservation by ovarian stimulation and concurrent aromatase inhibitor

会议

Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inf

会议